Bacteriophages (phages) exhibit excessive genetic variety, and the mosaic nature of the shared genetic pool makes quantifying phage relatedness a shifting goal. Early parameters for clustering of associated Mycobacteria and Arthrobacter phage genomes relied on nucleotide identification thresholds however, extra just lately, clustering of Gordonia and Microbacterium phages has been carried out in line with shared gene content. Singleton phages lack the nucleotide identification and/or shared gene content required for clustering newly sequenced genomes with identified phages.
Whole genome metrics of novel Arthrobacter phage BlueFeather, initially designated a putative singleton, confirmed low nucleotide identification however excessive amino acid and gene content similarity with Arthrobacter phages initially assigned to Clusters FE and FI. Gene content similarity revealed that BlueFeather shared genes with these phages in extra of the parameter for clustering Gordonia and Microbacterium phages. Single gene analyses revealed proof of horizontal gene switch between BlueFeather and phages in distinctive clusters that infect a spread of bacterial hosts. Our findings spotlight the benefit of utilizing shared gene content to check seemingly genetically remoted phages and have resulted in the reclustering of BlueFeather, a putative singleton, in addition to former Cluster FI phages, right into a newly expanded Cluster FE
Isolation and Characterization of Shiga Toxin Bacteriophages
Shiga toxin (Stx) phages might be induced from Stx-producing Escherichia coli strains (STEC) or might be remoted as free virions from completely different samples. Here we describe strategies used for the detection, enumeration, and isolation of Stx bacteriophages. Stx phages are temperate phages positioned in the genome of STEC. Their induction from the host pressure cultures is achieved by completely different inducing brokers, mitomycin C being one of the mostly used.
Detection of infectious Stx phages requires the manufacturing of seen plaques in a confluent garden of the host pressure utilizing a double agar layer technique. However, as the plaques produced by Stx phages are sometimes barely seen and there’s a risk that non-Stx phages may also be induced from the pressure, a hybridization step ought to be added to acknowledge and correctly enumerate the lysis plaques generated after induction. Molecular strategies may also be used to determine and enumerate Stx phages.
Real-time quantitative PCR (qPCR) is the most correct technique for absolute quantification, though it can not decide the infectivity of Stx phages. qPCR may also be helpful for the detection of free Stx phage virions in numerous pattern sorts.Stx phages induced from lysogenic bacterial strains might be purified by cesium chloride density gradients; this protocol additionally helps to particularly discriminate Stx phages from different prophages current in the genome of the host pressure by choosing the phages expressing the Stx gene. High titer suspensions of Stx phages obtained after induction of giant volumes of bacterial cultures and lysate focus permits phage characterization by electron microscopy research and genomic analysis.
Expression of virulence elements by Pseudomonas aeruginosa biofilm after bacteriophage an infection
The use of bacteriophages for the therapy of bacterial infections has been extensively studied. Nonetheless, the stress response concerning bacteriophage an infection and the expression of virulence elements of Pseudomonas aeruginosa after phage an infection is poorly mentioned. In this examine, we evaluated biofilm formation capability and expression of virulence elements of P. aeruginosa after bacteriophage an infection.
Biofilm progress charges, biofilm morphology, pyocyanin manufacturing and elastase exercise have been evaluated after 2, 8, 24 and 48 h of co-cultivation with bacteriophages that was just lately characterised and confirmed to be infective in direction of medical isolates.

In parallel, quantitative real-time polymerase chain reactions have been carried out to confirm the expression of virulence-related genes. Bacteriophages promoted substantial modifications in P. aeruginosa biofilm progress at early co-culture time. In addition, at Eight h, we noticed that some cultures developed filaments. Although bacteriophages didn’t alter each pyocyanin and protease exercise, modifications on the expression stage of genes associated to virulence elements have been detected. Usually, lasI, pslA, lasB and phzH genes have been upregulated after 2 and 48 h of co-culture. These outcomes spotlight the want for in depth investigation of pathways and molecules concerned in phage an infection, since the transcriptional modifications would recommend a response activation by P. aeruginosa.
Structural Insights into gp16 ATPase in the Bacteriophage ϕ29 DNA Packaging Motor
Biological motors, ubiquitous in dwelling methods, convert chemical vitality into completely different sorts of mechanical motions crucial to mobile features. Gene product 16 (gp16) in bacteriophage ϕ29 is amongst the strongest biomotors identified, which adopts a multisubunit ring-shaped construction and hydrolyzes ATP to package deal double-stranded DNA (dsDNA) right into a preformed procapsid. Here we report the crystal construction of the C-terminal area of gp16 (gp16-CTD).
Structure-based alignment and molecular dynamics simulations revealed a necessary binding floor of gp16-CTD for prohead RNA, a singular part of the motor complicated. Furthermore, our simulations highlighted a dynamic interaction between the N-terminal area and the CTD of gp16, which can play a task in driving motion of DNA into the procapsid. Lastly, we assembled an atomic structural mannequin of the full ϕ29 dsDNA packaging motor complicated by integrating structural and experimental information from a number of sources. Collectively, our findings supplied a refined inchworm-revolution mannequin for dsDNA translocation in bacteriophage ϕ29 and prompt how the particular person domains of gp16 work collectively to energy such translocation.
Mapping the purposeful panorama of the receptor binding area of T7 bacteriophage by deep mutational scanning
The interplay between a bacteriophage and its host is mediated by the phage’s receptor binding protein (RBP). Despite its basic function in governing phage exercise and host vary, molecular guidelines of RBP perform stay a thriller. Here, we systematically dissect the purposeful function of each residue in the tip area of T7 phage RBP (1660 variants) by growing a high-throughput, locus-specific, phage engineering technique.
This wealthy dataset allowed us to cross examine purposeful profiles throughout hosts to exactly determine areas of purposeful significance, many which have been beforehand unknown. Substitution patterns confirmed host-specific variations in place and physicochemical properties of mutations, revealing molecular adaptation to particular person hosts.
Cre Recombinant Adenovirus |
ADV-005 |
Cell Biolabs |
50 ?L |
EUR 891 |
Description: Premade recombinant adenovirus containing the Cre gene |
Cre Rabbit pAb |
A18151-100ul |
Abclonal |
100 ul |
EUR 308 |
Cre Rabbit pAb |
A18151-200ul |
Abclonal |
200 ul |
EUR 459 |
Cre Rabbit pAb |
A18151-20ul |
Abclonal |
20 ul |
EUR 183 |
Cre Rabbit pAb |
A18151-50ul |
Abclonal |
50 ul |
EUR 223 |
Anti-Cre antibody |
STJ140003 |
St John's Laboratory |
300 µg |
EUR 270 |
Description: Goat polyclonal antibody to Cre recombinase. Cre recombinase is a tyrosine recombinase enzyme derived from the P1 bacteriophage. The enzyme (38 kDa) is a member of the Integrase family of site specific recombinase and it is known to catalyse the site specific recombination event between two DNA recognition sites (loxP sites). |
Luciferase-2A-CRE, (GFP-Bsd) lentiviral particles |
LVP411 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 507 |
Description: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the same suCMV promoter. A GFP-Blasticidin fusion dual marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS. |
Luciferase-2A-CRE, (GFP-Puro) lentiviral particles |
LVP412 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 507 |
Description: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the same suCMV promoter. A GFP-Puromycin fusion dual marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS. |
Luciferase-2A-CRE, (RFP-Bsd) lentiviral particles |
LVP413 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 507 |
Description: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the same suCMV promoter. A RFP-Blasticidin fusion dual marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS. |
Luciferase-2A-CRE, (RFP-Puro) lentiviral particles |
LVP414 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 507 |
Description: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the same suCMV promoter. A RFP-Puromycin fusion dual marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS. |
Recombinant (E. Coli) Creatininase (500 U/mg) |
CRE-02 |
Alpha Diagnostics |
500,000 U |
EUR 2760 |
M13 Bacteriophage Antibody (Biotin) |
abx413451-01mg |
Abbexa |
0.1 mg |
EUR 1010 |
|
P1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV) |
LV739457 |
ABM |
1.0 ug DNA |
Ask for price |
P1 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC) |
LV739461 |
ABM |
1.0 ug DNA |
Ask for price |
P1 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a) |
LV739462 |
ABM |
1.0 ug DNA |
Ask for price |
Micrococcin P1 |
M055-0.5MG |
TOKU-E |
0.5 mg |
EUR 318 |
Micrococcin P1 |
M055-2.5MG |
TOKU-E |
2.5 mg |
EUR 1040 |
P1 Protein |
abx160013-1mg |
Abbexa |
1 mg |
EUR 1678 |
|
Cecropin P1 |
H-5718.0500 |
Bachem |
0.5mg |
EUR 139 |
Description: Sum Formula: C147H253N45O43; CAS# [125667-96-1] |
Cecropin P1 |
H-5718.1000 |
Bachem |
1.0mg |
EUR 206 |
Description: Sum Formula: C147H253N45O43; CAS# [125667-96-1] |
CRE (Neo), CMV lentivirus |
LVP297 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 349 |
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase with Neomycin marker, provided in DMEM medium with 10% FBS. |
CRE (Bsd), CMV lentivirus |
LVP336 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 349 |
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase with Blasticidin marker, provided in DMEM medium with 10% FBS. |
CRE (Puro), CMV lentivirus |
LVP339 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 349 |
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase with Puromycin marker, provided in DMEM medium with 10% FBS. |
CRE (Bsd), EF1a lentivirus |
LVP519 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 349 |
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under EF1a promoter with Blasticidin marker, provided in DMEM medium with 10% FBS. |
CRE (Puro), EF1a lentivirus |
LVP520 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 349 |
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under EF1a promoter with Puromycin marker, provided in DMEM medium with 10% FBS. |
CRE (Neo), EF1a lentivirus |
LVP521 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 349 |
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under EF1a promoter with Neomycin marker, provided in DMEM medium with 10% FBS. |
CRE (Puro), CAG lentivirus |
LVP573 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 349 |
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under CAG promoter with Puromycin marker, provided in DMEM medium with 10% FBS. |
CRE (Bsd), CAG lentivirus |
LVP574 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 349 |
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under CAG promoter with Blasticidin marker, provided in DMEM medium with 10% FBS. |
CRE (Neo), CAG lentivirus |
LVP575 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 349 |
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under CAG promoter with Neomycin marker, provided in DMEM medium with 10% FBS. |
AAV2-Cre Control Virus |
AAV-310 |
Cell Biolabs |
50 ?L |
EUR 1018 |
Description: Cre control virus of AAV serotype 2. |
AAV1-Cre Control Virus |
AAV-311 |
Cell Biolabs |
50 ?L |
EUR 1018 |
Description: Cre control virus of AAV serotype 1. |
AAV3-Cre Control Virus |
AAV-313 |
Cell Biolabs |
50 ?L |
EUR 1018 |
Description: Cre control virus of AAV serotype 3. |
AAV4-Cre Control Virus |
AAV-314 |
Cell Biolabs |
50 ?L |
EUR 1018 |
Description: Cre control virus of AAV serotype 4. |
AAV5-Cre Control Virus |
AAV-315 |
Cell Biolabs |
50 ?L |
EUR 1018 |
Description: Cre control virus of AAV serotype 5. |
AAV6-Cre Control Virus |
AAV-316 |
Cell Biolabs |
50 ?L |
EUR 1018 |
Description: Cre control virus of AAV serotype 6. |
Der-P1 Der P1 Protein Recombinant Protein |
PROTP08176 |
BosterBio |
Regular: 0.5mg |
EUR 788 |
Description: The E.Coli derived recombinant protein contains the Dermatophagoides pteronyssinus Dust Mite Der P1 protein (a.a. 20-320) and fused to a 6 His Tag at C-terminus, having a total Mw of 34.5kDa, pI 5.6. |
P1 ORF Vector (Human) (pORF) |
ORF027336 |
ABM |
1.0 ug DNA |
Ask for price |
Luciferase-2A-CRE (Bsd), lentiviral particles, in vivo ready |
LVP304-PBS |
GenTarget |
5 x107 IFU/ml x 200ul |
EUR 862 |
Description: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the same suCMV promoter. A Blasticidin marker was expressed under RSV promoter. Virus concentrated and buffer changed into PBS solution. |
Luciferase-2A-CRE (Puro), lentiviral particles, in vivo ready |
LVP409-PBS |
GenTarget |
5 x107 IFU/ml x 200ul |
EUR 862 |
Description: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the same suCMV promoter. A Puromycin marker was expressed under RSV promoter. Virus concentrated and buffer changed into PBS solution. |
Luciferase-2A-CRE (Neo), lentiviral particles, in vivo ready |
LVP410-PBS |
GenTarget |
5 x107 IFU/ml x 200ul |
EUR 862 |
Description: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the same suCMV promoter. A Neomycin marker was expressed under RSV promoter. Virus concentrated and buffer changed into PBS solution. |
Cecropin P1 porcine |
C214-1MG |
TOKU-E |
1 mg |
EUR 274 |
Der P1 Protein |
20-abx260104 |
Abbexa |
-
EUR 885.00
-
EUR 342.00
-
EUR 1372.00
|
|
|
Nuclease P1 Antibody |
20-abx300888 |
Abbexa |
-
EUR 411.00
-
EUR 1845.00
-
EUR 599.00
-
EUR 182.00
-
EUR 300.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
SZL P1-41 |
B7745-10 |
ApexBio |
10 mg |
EUR 321 |
SZL P1-41 |
B7745-100 |
ApexBio |
100 mg |
EUR 1750 |
SZL P1-41 |
B7745-25 |
ApexBio |
25 mg |
EUR 628 |
SZL P1-41 |
B7745-5 |
ApexBio |
5 mg |
EUR 203 |
SZL P1-41 |
B7745-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 218 |
SZL P1-41 |
B7745-50 |
ApexBio |
50 mg |
EUR 1044 |
Nuclease P1 Antibody |
1-CSB-PA328459LA01PEU |
Cusabio |
|
|
|
Description: A polyclonal antibody against Nuclease P1. Recognizes Nuclease P1 from Penicillium citrinum. This antibody is Unconjugated. Tested in the following application: ELISA |
CRE (GFP-Puro),
CAG lentivirus |
LVP576 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 349 |
Description: Pre-made lentiviral particles bicistronically express (under CAG promoter) nuclear permeable CRE recombinase and the GFP marker under the same suCAG promoter. A Puromycin marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS. |
CRE (RFP-Bsd),
CAG lentivirus |
LVP577 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 349 |
Description: Pre-made lentiviral particles bicistronically express (under CAG promoter) nuclear permeable CRE recombinase and the RFP marker under the same suCAG promoter. A Blasticidin marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS. |
CRE (RFP-Puro),
CAG lentivirus |
LVP578 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 349 |
Description: Pre-made lentiviral particles bicistronically express (under CAG promoter) nuclear permeable CRE recombinase and the RFP marker under the same suCAG promoter. A Puromycin marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS. |
CRE-2A-GFP, CMV lentivirus |
LVP804 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 349 |
Description: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the GFP marker under the same suCMV promoter. No any antibioic selection marker. Virus provided in DMEM medium with 10% FBS. |
CRE-2A-RFP, CMV lentivirus |
LVP805 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 349 |
Description: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the RFP marker under the same suCMV promoter. No any antibioic selection marker. Virus provided in DMEM medium with 10% FBS. |
Luciferase-2A-CRE, (GFP-Bsd) lentiviral particles, in vivo ready |
LVP411-PBS |
GenTarget |
5 x107 IFU/ml x 200ul |
EUR 862 |
Description: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the same suCMV promoter. A GFP-Blasticidin fusion dual marker was expressed under RSV promoter. Virus concentrated and buffer changed into PBS solution. |
Luciferase-2A-CRE, (GFP-Puro) lentiviral particles, in vivo ready |
LVP412-PBS |
GenTarget |
5 x107 IFU/ml x 200ul |
EUR 862 |
Description: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the same suCMV promoter. A GFP-Puromycin fusion dual marker was expressed under RSV promoter. Virus concentrated and buffer changed into PBS solution. |
Luciferase-2A-CRE, (RFP-Bsd) lentiviral particles, in vivo ready |
LVP413-PBS |
GenTarget |
5 x107 IFU/ml x 200ul |
EUR 862 |
Description: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the same suCMV promoter. A RFP-Blasticidin fusion dual marker was expressed under RSV promoter. Virus concentrated and buffer changed into PBS solution. |
Luciferase-2A-CRE, (RFP-Puro) lentiviral particles, in vivo ready |
LVP414-PBS |
GenTarget |
5 x107 IFU/ml x 200ul |
EUR 862 |
Description: Pre-made lentiviral particles bicistronically express individual firefly luciferase and nuclear permeable CRE recombinase under the same suCMV promoter. A RFP-Puromycin fusion dual marker was expressed under RSV promoter. Virus concentrated and buffer changed into PBS solution. |
Arabidopsis thaliana NADP-dependent alkenal double bond reductase P1 (P1) |
1-CSB-EP654400DOA |
Cusabio |
-
EUR 611.00
-
EUR 309.00
-
EUR 1827.00
-
EUR 939.00
-
EUR 1218.00
-
EUR 397.00
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Arabidopsis thaliana NADP-dependent alkenal double bond reductase P1(P1) expressed in E.coli |
Arabidopsis thaliana NADP-dependent alkenal double bond reductase P1 (P1) |
1-CSB-EP654400DOAe1 |
Cusabio |
-
EUR 727.00
-
EUR 425.00
-
EUR 1943.00
-
EUR 1055.00
-
EUR 1335.00
-
EUR 513.00
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Arabidopsis thaliana NADP-dependent alkenal double bond reductase P1(P1) expressed in E.coli |
P1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-C-term-HA) |
LV739458 |
ABM |
1.0 ug DNA |
Ask for price |
P1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) |
LV739459 |
ABM |
1.0 ug DNA |
Ask for price |
P1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
LV739460 |
ABM |
1.0 ug DNA |
Ask for price |
CRE (Neo), CMV lentivirus, in PBS |
LVP297-PBS |
GenTarget |
5 x107 IFU/ml x 200ul |
EUR 710 |
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase with Neomycin marker. Virus concentrated and buffer changed into provided in PBS solution |
CRE (Bsd), CMV lentivirus in PBS |
LVP336-PBS |
GenTarget |
5 x107 IFU/ml x 200ul |
EUR 710 |
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase with Blasticidin marker. Virus concentrated and buffer changed into provided in PBS solution |
CRE-2A-GFP (Bsd), CMV lentivirus |
LVP337 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 349 |
Description: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the GFP marker under the same suCMV promoter. A Blasticidin marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS. |
CRE-2A-RFP (Puro), CMV lentivirus |
LVP338 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 349 |
Description: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the RFP marker under the same suCMV promoter. A Puromycin marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS. |
CRE (Puro), CMV lentivirus in PBS |
LVP339-PBS |
GenTarget |
5 x107 IFU/ml x 200ul |
EUR 710 |
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase with puromycin marker. Virus concentrated and buffer changed into provided in PBS solution |
CRE-2A-GFP (Puro), CMV lentivirus |
LVP407 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 349 |
Description: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the GFP marker under the same suCMV promoter. A Puromycin marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS. |
CRE-2A-GFP (Neo), CMV lentivirus |
LVP408 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 349 |
Description: Pre-made lentiviral particles bicistronically express individual nuclear permeable CRE recombinase and the GFP marker under the same suCMV promoter. A Neomycin marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS. |
CRE (Bsd), EF1a lentivirus in PBS |
LVP519-PBS |
GenTarget |
5 x107 IFU/ml x 200ul |
EUR 710 |
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under EF1a promoter with Blasticidin marker. Virus concentrated and buffer changed into provided in PBS solution |
CRE (Puro), EF1a lentivirus in PBS |
LVP520-PBS |
GenTarget |
5 x107 IFU/ml x 200ul |
EUR 710 |
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under EF1a promoter with puromycin marker. Virus concentrated and buffer changed into provided in PBS solution |
CRE (Neo), EF1a lentivirus, in PBS |
LVP521-PBS |
GenTarget |
5 x107 IFU/ml x 200ul |
EUR 710 |
Description: Pre-made lentiviral particles expressing nuclear permeable CRE recombinase under EF1a promoter with Neomycin marker. Virus concentrated and buffer changed into provided in PBS solution |
CRE-2A-RFP (Bsd), EF1a lentivirus |
LVP522 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 349 |
Description: Pre-made lentiviral particles bicistronically express (under EF1a promoter) nuclear permeable CRE recombinase and the RFP marker under the same suEF1a promoter. A Blasticidin marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS. |
CRE-2A-RFP (Puro), EF1a lentivirus |
LVP523 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 349 |
Description: Pre-made lentiviral particles bicistronically express (under EF1a promoter) nuclear permeable CRE recombinase and the RFP marker under the same suEF1a promoter. A Puromycin marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS. |
CRE-2A-RFP (Neo), EF1a lentivirus |
LVP524 |
GenTarget |
1x107 IFU/ml x 200ul |
EUR 349 |
Description: Pre-made lentiviral particles bicistronically express (under EF1a promoter) nuclear permeable CRE recombinase and the RFP marker under the same suEF1a promoter. A Neomycin marker was expressed under RSV promoter. Virus provided in DMEM medium with 10% FBS. |
We found gain-of-function variants in opposition to resistant hosts and host-constricting variants that eradicated sure hosts. To reveal therapeutic utility, we engineered extremely lively T7 variants in opposition to urinary tract pathogen. Our method presents a generalized framework for characterizing sequence-function relationships in lots of phage-bacterial methods.